PSYCHEDELIC CAPITAL

The Gold Standard in Psychedelic Investment

Psychedelic Capital is a virtual investment conference, and a platform to showcase the top companies, latest IPOs, newest opportunities, and deepest industry insights.


Psychedelic Capital: Feb 2021
Feb 25, 2021, 4:15pm EST
$50.00 $25.00

*If you have a coupon code, you can use it during checkout.
**Purchasing a ticket gets you lifetime access to recordings.

Networking at its Finest

Build Relationships

Aside from getting access to pre-IPO investment opportunities, our events allow attendees to join in group discussions, chat directly with presenting companies, and speed network 1-on-1 with attendees. It's just like being at a real conference.

Raise Funds

As a presenting sponsor, you get to connect directly with some of the earliest moving investors in the psychedelic industry. We'll supply you with a list of interested contacts after the show, and you get to distribute your pitch deck to our entire audience of 2000+ investors.

Discover the Agenda

*All times are Eastern Standard Timezone.

Add to your calendar

4:15pm: MagicMed Industries

MagicMed Industries

Our mission is to support and enable the commercialization of psychedelic-derived pharmaceuticals for brain and mental health. MagicMed is developing a library of psychedelic derivative molecules for licensing to pharmaceutical and consumer goods companies.

Dr. Joseph Tucker

Chief Executive Officer
MagicMed Industries

Dr. Joseph Tucker has 20 years’ experience as a biotechnology entrepreneur and C-Suite executive,…

4:45pm: Algernon Pharmaceuticals

Algernon Pharmaceuticals

Algernon is a drug re-purposing company that investigates safe, already approved drugs, including naturally occurring compounds, for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off-label prescription writing.

David Nutt

Consultant
Algernon Pharmaceuticals Inc.

David Nutt FRCP, FRCPsych, FMedSci, is a psychiatrist at Imperial College London. He trained at…

Cyndi Edwards

Host
PR Media Now

Cyndi Edwards has 25 years of TV broadcasting experience. Her journalism career began in news with…

Christopher Moreau

CEO
Algernon Pharmaceuticals Inc.

Mr. Moreau is a seasoned business professional in the life sciences sector with a strong background…

5:15pm: Investment Banks

Henri Sant-Cassia

Board Director
The Conscious Fund, Microdose Psychedelic Insights

A Co-Founding Partner at The Conscious Fund, he has been involved in both commercial and non-profit…

Michael Huttner

Managing Director

Michael Huttner is a corporate and political strategist, attorney and entrepreneur. Prior to…

Michael Astone

Director
Cantor Fitzgerald

I am a senior Mergers & Acquisition professional and Financier focused on Diversified Industries…

5:45pm: Lobe Sciences

Lobe Sciences

Lobe Sciences is a dedicated team of pioneering scientists, engineers, and operators committed to the investigation and development of treatments using alternative and nontraditional mechanisms for better health.

Philip Young

CEO & Director
Lobe Sciences

Mr. Young is an analytical and results-driven life sciences executive who has successfully managed…

Maghsoud Dariani

Chief Science Officer
Lobe Sciences

Concurrent to leading science and technology efforts at LOBE, Maghsoud is also President and CEO of…

6:15pm: Retail Investors

Richard Skaife

Chair

Richard is a founding partner at The Conscious Fund and a board member of MicroDose and Hive Bio. A…

Jeremy Prinsen

Business Development
Entheon Biomedical

Brandon Colwell

Co-Founder
Sagacity Capital Media

Brandon has been covering the small cap space within North America for the last 5 years having…

Jeff Nielson

Senior Editor
Psychedelic Stock Watch

The Senior Editor for Psychedelic Stock Watch, Jeff is an experienced writer and editor who has…

7:15pm: ShroomBloom

ShroomBloom Labs

Founded by pioneers of the specialty and medicinal mushroom growing industry, ShroomBloom is the first legal psychedelic company dedicated uniquely to growing, and scaling psilocybin mushroom production. ShroomBloom is conducting a biotech research and development program to industrialize the cultivation of psychedelic mushrooms. ShroomBloom’s mission is to become the leading global supplier of the highest yielding medical grade psilocybin mushrooms, with lower production costs, within a cGMP production facility.

Patrick Lemieux

Co-CEO
ShroomBloom Labs

After a successful career in the telecom industry, Patrick took on the new challenge of automating…

Isabela Lemieux

Co-CEO
ShroomBloom Labs

Isabela has over 5 years of experience working at the forefront of the mushroom industry. She…

Join the Ranks of the Industry's Brightest Stars

Do you think your company would be a fit for Psychedelic Capital? Our events run every month, and we strive to work with the innovators of tomorrow.

My Company is Interested in PsyCap

"It defines the ecosystem"

Cody Shandraw
Director, Ambria Capital

Change the color to match your brand or vision, add your logo, choose the perfect layout, modify menu settings, add animations, add shape dividers, increase engagement with call to action and more.

Cody Shandraw
Director, Ambria Capital

Change the color to match your brand or vision, add your logo, choose the perfect layout, modify menu settings, add animations, add shape dividers, increase engagement with call to action and more.

Cody Shandraw
Director, Ambria Capital

PsyCap is Getting Bigger by the Day

30+

Sponsors

120+

Speakers

2500+

Attendees

500,000+

Impressions

Featured Participants

Each PsyCap event includes group panel discussions with leading experts representing national and international firms outside of the psychedelic industry.

Event Partners

Frequently Asked Questions

Yes, every ticket holder will automatically get lifetime access to recordings.

Yes, once we release recordings (typically within 5 business days after the event), each company’s pitch deck will be accessible along with the video in the My Content section of the website.

The heart of our events come in the networking value of being there on the day of the event. Not only will you be able to watch the sessions, but you’ll also be able to ask questions during the show, network both in group settings and 1-on-1 meetings, and you’ll get dedicated time to talk with presenting companies.

For the full experience, it’s recommended that you use a personal computer running Chrome 79+ or Firefox 76+. Safari will run in lite (non-interactive) mode, meaning you can watch the panels but not interact with the features of the platform.

You’ll get an email the morning of the event with a link to access the platform.

Recordings will be automatically added to the My Content section of the website for each ticket holder typically within 5 business days after the event.

Get Tickets Now

*If you have a coupon code, you can use it during checkout.
**Purchasing a ticket gets you lifetime access to recordings.

Privacy Preference Center